Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
McKinsey
Accenture
Medtronic
Dow
Chubb
McKesson
Queensland Health
Boehringer Ingelheim

Generated: October 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: hyaluronidase recombinant human

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Halozyme Therap
HYLENEX RECOMBINANT
hyaluronidase recombinant human
INJECTABLE;INJECTION021859NDAHalozyme, Inc.18657-117-044 BOX in 1 CARTON (18657-117-04) > 1 VIAL in 1 BOX (18657-117-02) > 1 mL in 1 VIAL (18657-117-01)
Halozyme Therap
HYLENEX RECOMBINANT
hyaluronidase recombinant human
INJECTABLE;INJECTION021859NDABaxter Healthcare Corporation60977-319-034 BOX in 1 CARTON (60977-319-03) > 1 VIAL, SINGLE-DOSE in 1 BOX (60977-319-02) > 1 mL in 1 VIAL, SINGLE-DOSE (60977-319-44)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cerilliant
UBS
Farmers Insurance
Mallinckrodt
US Army
Chubb
Daiichi Sankyo
Deloitte
Argus Health

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot